Skip to main content

Anthony E. Altig

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Anthony E. Altig

Anthony E. Altig is recorded as Board Member at Assembly Biosciences, Inc. (ASMB). Assembly Biosciences, Inc. reported in an 8-K filed June 5, 2026 that Anthony E. Altig was appointed Director, effective June 4, 2026. Assembly Biosciences, Inc. reported in an 8-K filed June 3, 2024 that Anthony E. Altig was appointed Director, effective May 29, 2024. Assembly Biosciences, Inc. reported in an 8-K filed May 30, 2023 that Anthony E. Altig was appointed Director, effective May 25, 2023.

“The stockholders elected of the following to serve on the Company's Board of Directors until the Company's 2027 annual meeting of stockholders and until their successors are duly elected and qualified: Anthony E. Altig; Tomas Cihlar, Ph.D.; Gina Consylman; Robert D. Cook II; Sir Michael Houghton, Ph.D.; Lisa R. Johnson-Pratt, M.D.; Susan Mahony, Ph.D.; John G. McHutchison, A.O., M.D.; and Jason A. Okazaki.”
Assembly Biosciences, Inc. Form 8-K, filed June 5, 2026 · Read the filing
“William R. Ringo, Jr., Anthony E. Altig, Tomas Cihlar, Ph.D., Gina Consylman, Robert D. Cook II, Sir Michael Houghton, Ph.D., Lisa R. Johnson-Pratt, M.D., Susan Mahony, Ph.D., John G. McHutchison, A.O., M.D. and Jason A. Okazaki were each elected to serve on the Company's Board of Directors until the Company's 2025 annual meeting of stockholders and until their successors are duly elected and qualified.”
Assembly Biosciences, Inc. Form 8-K, filed June 3, 2024 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Assembly Biosciences, Inc.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.